CJC-1295 DAC is a synthetic, long-acting analogue of growth hormone-releasing hormone, or GHRH, designed for research involving growth-hormone signaling, IGF-1 pathways, metabolic regulation, recovery models, and body-composition-related biomarkers.
In human clinical research, CJC-1295 has been studied as a long-acting GHRH analogue for its effects on growth hormone and IGF-1 secretion.
Potential Research Benefits
- Growth-hormone signaling research
- IGF-1 pathway research
- Lean-mass and body-composition biomarkers
- Recovery and tissue-repair pathway research
- Muscle-protein synthesis pathways
- Exercise-recovery research
- Fat-metabolism and lipolysis-related research
- Sleep-quality and slow-wave sleep research
- Cellular-repair and regeneration pathways
- Bone-density and connective-tissue research
- Collagen-turnover research
- Metabolic-health marker research
- Age-related hormone-signaling research
- Energy, vitality, and wellness-marker research
- Endocrine-function research
For laboratory and research use only. Not for human consumption.
This product is a research chemical. It is not a drug, food or cosmetic, and it is not for human or veterinary use. It is sold exclusively to qualified researchers and licensed laboratories.
This product has not been evaluated or approved by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease.
